Search

Your search keyword '"Tolosa, C."' showing total 46 results

Search Constraints

Start Over You searched for: Author "Tolosa, C." Remove constraint Author: "Tolosa, C." Topic male Remove constraint Topic: male
46 results on '"Tolosa, C."'

Search Results

1. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

2. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: 'AbSeS', a multinational observational cohort study and ESICM Trials Group Project

3. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

4. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

5. Predictors of active cancer thromboembolic outcomes

6. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

7. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

8. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

9. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy

10. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

11. A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility

12. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

13. Clinical presentation and outcome of venous thromboembolism in COPD

14. Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism

15. D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer

16. Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

17. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

18. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism

19. Platelet count and outcome in patients with acute venous thromboembolism

20. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

21. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

22. Unsuspected pulmonary embolism in patients with cancer

23. Usefulness of Thrombophilia Testing in Venous Thromboembolic Disease

24. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism

25. A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis

26. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

27. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry

28. Factors associated with elevated pulmonary arterial pressure levels on the echocardiographic assessment in patients with prior pulmonary embolism

29. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer

30. Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism

31. Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal function

32. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs

33. Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis

34. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry

35. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis

36. Venous thromboembolism in patients with intracranial haemorrhage

37. [Primary antiphospholipid syndrome: study of 27 patients]

38. [Tumorous lymphedema of the penis. Report of verrucous elephantiasis. A brief case. Preliminary note]

39. Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism

40. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

41. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

42. Timing and characteristics of venous thromboembolism after noncancer surgery

43. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

44. DVT Management and Outcome Trends, 2001 to 2014

45. Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

46. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

Catalog

Books, media, physical & digital resources